Article citationsMore>>

Wang, W.X., Rajeev, B.W., Stromberg, A.J., Ren, N., Tang, G., Huang, Q., Rigoutsos, I. and Nelson, P.T. (2008) The expression of microRNA miR-107 decreases early in Alzheimer's disease and may accelerate disease progression through regulation of beta-site amyloid precursor protein-cleaving enzyme 1. The Journal of Neuroscience, 28, 1213-1223. doi:10.1523/JNEUROSCI.5065-07.2008

has been cited by the following article:

• TITLE: Identification of regulatory sequence signatures in microRNA precursors implicated in neurological disorders

  AUTHORS: Sayak Ganguli, Sasti Gopal Das, Hirak Jyoti Chakraborty, Sohini Gupta, Abhijit Datta

  KEYWORDS: Neurological Diseases; Regulatory Motif Signatures; Parkinson’s Disease; Alzheimer’s Disease; Huntington Disease

  JOURNAL NAME: Advances in Bioscience and Biotechnology, Vol.4 No.5A, May 27, 2013

  ABSTRACT: MicroRNAs have emerged as one of the major classes of non-coding RNAs. Recent reports have placed them in high abundance in the nervous system, having key roles in development. Neurological disorders such as Parkinson’s disease, Alzheimer’s disease as well as Huntington disease have also been studied and several microRNAs associated with diseases pathogenesis have been identified. Various such findings indicate differential expression levels of many of these microRNAs. Such changes in the expression levels not only indicate towards a control of the biogenesis of these microRNAs but also indicate towards critical yet unelucidated roles of regulatory proteins, which probably act in concert to control the production or maturation of these molecules. In this work, a collection of overrepresented regulatory motif signatures were identified in the DNA and RNA sequences of the precursor microRNAs. The identification of such regulatory sequence signatures promises to provide new insights into many facets of microRNA regulation and neurological disorders.